Tamara Lotan

Tamara Lotan

Johns Hopkins University

H-index: 58

North America-United States

Contact Tamara Lotan

About Tamara Lotan

Tamara Lotan, With an exceptional h-index of 58 and a recent h-index of 48 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Prostate Cancer, PTEN, mTOR/PI3K signaling.

His recent articles reflect a diverse array of research interests and contributions to the field:

Comparison of whole slide image–based deep learning algorithms and genomic classifiers for assessing the risk of prostate cancer metastasis in surgically treated patients.

Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer

FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer

Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma

Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small

PD13-08 ERG STATUS IN MRI VISIBLE TUMORS PREDICTS GRADE RECLASSIFICATION IN ACTIVE SURVEILLANCE

High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset

TFE3-Rearranged PEComa/PEComa-like Neoplasms: Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy

Tamara Lotan Information

University	Johns Hopkins University
Position	Professor and Deputy Director for Research Department of Pathology
Citations(all)	13461
Citations(since 2020)	8738
Cited By	8208
hIndex(all)	58
hIndex(since 2020)	48
i10Index(all)	150
i10Index(since 2020)	136
Email	Access Email
University Profile Page	Johns Hopkins University
Google Scholar	View Google Scholar Profile

Tamara Lotan Skills & Research Interests

Prostate Cancer

PTEN

mTOR/PI3K signaling

Top articles of Tamara Lotan

Comparison of whole slide image–based deep learning algorithms and genomic classifiers for assessing the risk of prostate cancer metastasis in surgically treated patients.

2024/2/1

Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer

npj Genomic Medicine

2024/1/22

Benjamin Miller

H-Index: 29

John R Lozada

H-Index: 8

Jinhua Wang

H-Index: 31

Eugene Shenderov

H-Index: 7

Francisco Pereira Lobo

H-Index: 14

Luigi Marchionni

H-Index: 37

Tamara Lotan

H-Index: 36

FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer

Cancer Research Communications

2024/1/18

Thiago Vidotto

H-Index: 8

Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma

Scientific reports

2024/1/17

Nirmish Singla

H-Index: 19

Eugene Shenderov

H-Index: 7

Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small

The Oncologist

2024/1/11

Himisha Beltran

H-Index: 53

PD13-08 ERG STATUS IN MRI VISIBLE TUMORS PREDICTS GRADE RECLASSIFICATION IN ACTIVE SURVEILLANCE

The Journal of Urology

2024/5

Zhuo Tony Su

H-Index: 8

Zitong Wang

H-Index: 1

High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset

Modern Pathology

2024/5/1

Roy Elias

H-Index: 7

Jing Zhu

H-Index: 12

Nirmish Singla

H-Index: 19

Pedram Argani

H-Index: 63

TFE3-Rearranged PEComa/PEComa-like Neoplasms: Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy

The American Journal of Surgical Pathology

2024/4/10

Pedram Argani

H-Index: 63

Ezra Baraban

H-Index: 8

Christopher Gocke

H-Index: 32

Tamara Lotan

H-Index: 36

Prostate Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines

Journal of the National Comprehensive Cancer Network

2024/4/6

Nabil Adra

H-Index: 10

Yi An

H-Index: 5

Xin Gao

H-Index: 20

Shilpa Gupta

H-Index: 53

Tamara Lotan

H-Index: 36

Todd Morgan

H-Index: 10

Robert Reiter

H-Index: 41

Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate resistant prostate cancer

Stem Cells

2024/4/2

Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors

2024/3/22

Aneuploidy-associated SQLE gain promotes prostate cancer aggressiveness by altering lipid metabolism

Cancer Research

2024/3/22

Zhe Li

H-Index: 5

Targeting of macrophage PI3Kγin prostate cancer using Eganelisib (IPI-549) reprograms immune-suppressive infiltrating macrophages to enhance anti-tumor immune responses and …

Cancer Research

2024/3/22

Fan Shen

H-Index: 5

Xiaoxu Wang

H-Index: 14

Monali Praharaj

H-Index: 2

Multi-omics analysis reveals high chronic inflammation in African Americans compared to Native African Men with prostate cancer

Cancer Research

2024/3/22

Ezra Baraban

H-Index: 8

Melissa Davis

H-Index: 3

Michael Dixon

H-Index: 10

Isaac Kim

H-Index: 15

Clayton Yates

H-Index: 21

Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2: ERG Fusion Status in Prostate Cancer Using Whole Slide Images

Molecular Cancer Research

2024/2/14

Mohamed Omar

H-Index: 7

Zhuoran Xu

H-Index: 5

Massimo Loda

H-Index: 76

Luigi Marchionni

H-Index: 37

Comparison of pathologist and deep learning–based prostate cancer grading for prediction of metastatic outcomes in primary prostate cancer.

2024/2/1

Deep learning (DL) algorithms to predict prostate cancer progression on low/intermediate-risk needle core biopsies.

2024/2/1

Chien-Kuang Cornelia Ding

H-Index: 10

Thiago Vidotto

H-Index: 8

TRIUMPH: Phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline DNA repair gene mutations.

2023/2/20

Hao Wang

H-Index: 29

A novel prostate cancer subtyping classifier based on luminal and basal phenotypes

Cancer

2023/7/15

Yang Liu

H-Index: 18

Xin Zhao

H-Index: 38

Daniel E Spratt

H-Index: 44

Gerhardt Attard

H-Index: 54

Phase II randomized study of salvage radiation therapy plus enzalutamide or placebo for high-risk prostate-specific antigen recurrent prostate cancer after radical …

Journal of Clinical Oncology

2023/2/20

Steven Miller

H-Index: 10

Ryan Phillips

H-Index: 3

Tamara Lotan

H-Index: 36

Mario Eisenberger

H-Index: 62

Stanley L Liauw

H-Index: 24

Daniel E Spratt

H-Index: 44

Felix Feng

H-Index: 71

Hao Wang

H-Index: 29

See List of Professors in Tamara Lotan University(Johns Hopkins University)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine